Inflammatory biomarker-based clinical practice in patients with pneumonia: A systematic review of randomized controlled trials

1 BROWN J. S. Community-acquired pneumonia. Clinical medicine (London, England), 2012;12(6):538–543. Search in Google Scholar

2 KALANURIA A. A., ZIAI W., MIRSKI M. Ventilator-associated pneumonia in the ICU. Critical care (London, England). 2014;18(2):208. Search in Google Scholar

3 KARAKIOULAKI M., STOLZ D. Biomarkers in Pneumonia-Beyond Procalcitonin. International journal of molecular sciences. 2019;20(8):2004. Search in Google Scholar

4 BOBYLEV A. A., RACHINA S. A., AVDEEV S. N., KOZLOV R. S., MLADOV V. V. C-reactive protein evaluation in community acquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription. Kardiologiia. 2019;59(2S):40–46. Search in Google Scholar

5 BARAK-CORREN Y., BARAK-CORREN N., GILELES-HILLEL A., HEIMAN E. The effect of C-reactive protein on chest X-ray interpretation: A decision-making experiment among pediatricians. Pediatric pulmonology. 2021;56(6):1644–1650. Search in Google Scholar

6 ULM L., HOFFMAN S., NABAVI D., HERMANS M., MACKERT B. M., HAMILTON F., et al. The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke. Frontiers in neurology. 2017;8:153. Search in Google Scholar

7 HELLYER T. P., MCAULEY D. F., WALSH T. S., ANDERSON N., CONWAY M. A., SINGH S., et al. Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation. The Lancet. Respiratory medicine. 2020;8(2):182–191. Search in Google Scholar

8 BUTLER C. C., GILLESPIE D., WHITE P., BATES J., LOWE R., THOMAS-JONES E., et al. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. The New England journal of medicine. 2019;381(2):111–120. Search in Google Scholar

9 STOLZ D., CHRIST-CRAIN M., BINGISSER R., LEUPPI J., MIEDINGER D., MULLER C., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9–19 Search in Google Scholar

10 BRIEL M., SCHUETZ P., MUELLER B., YOUNG J., SCHILD U., NUSBAUMER C., et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Archives of internal medicine. 2008;168(18):2000–2008. Search in Google Scholar

11 LHOPITALLHIER L., KRONENBERG A., MEUWLY J. Y., LOCATELLY I., MUELLER Y., SENN N., et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ. 2021;374:n2132. Search in Google Scholar

12 MONTASSIER E., JAVAUDIN F., MOUSTAFA F., NANDJOU D., MAIGMAN M., HARDOUIN J., et al. Guideline-Based Clinical Assessment Versus Procalcitonin-Guided Antibiotic Use in Pneumonia: A Pragmatic Randomized Trial. Annals of emergency medicine. 2019;74(4):580–591. Search in Google Scholar

13 CHRIST-CRAIN M., STOLZ D., BINGISSER R., MULLER C., MIEDINGER D., HUBER P. R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. American journal of respiratory and critical care medicine. 2006;174(1):84–93. Search in Google Scholar

14 WUSSLER D., KOZHUHAROV N., TAVARES OLIVEIRA M., BOSSA A., SABTI Z., NOWAK A., et al. Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia. Clinical chemistry. 2019;65(12):1532–1542. Search in Google Scholar

15 WIRZ Y., MEIER M. A., BOUADMA L., LUYT C. E., WOLFF M., CHASTRE J., et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Critical care (London, England). 2018;22(1):191. Search in Google Scholar

16 LONG W., DENG X., ZHANG Y., LU G., XIE J., TANG J. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Respirology (Carlton, Vic.). 2011;16(5):819–824. Search in Google Scholar

17 SCHUETZ P., CHRIST-CRAIN M., THOMANN R., FALCONNIER C., WOLBERS M., WIDMER I., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302(10):1059–1066. Search in Google Scholar

18 CHRIST-CRAIN M., JACCARD-STOLZ D., BINGISSER R., GENCAY M. M., HUBER P. R., TAMM M., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet (London, England). 2004;363(9409):600–607. Search in Google Scholar

19 Z. MAZLAN M., A. H. ISMAIL M., ALI S., SALMUNA Z. N., WAN M. SHUKERI W. F., OMAR M. Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial. Anesthesiology intensive therapy. 2021;53(3):207–214. Search in Google Scholar

20 PIERRAKOS C., VELISSARIS D., BISDORFF M., MARSHALL J. C., VINCENT J. L. Biomarkers of sepsis: time for a reappraisal. Critical care (London, England). 2020;24(1):287. Search in Google Scholar

21 STOLZ D., SMYRNIOS N., EGGIMANN P., PARGGER H., THAKKAR N., SIEGEMUND M., et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. The European respiratory journal. 2009;34(6):1364–1375. Search in Google Scholar

22 OGASAWARA T., UMEZAWA H., NAITO Y., TAKEUCHI T., KATO S., YANO T., et al. Procalcitonin-guided antibiotic therapy in aspiration pneumonia and an assessment of the continuation of oral intake. Respiratory investigation. 2014;52(2):107–113. Search in Google Scholar

23 GAVAZZI G., DREVET S., DEBRAY M., BOSSON J. L., TIDADINI F., PACCALIN M., et al. Procalcitonin to reduce exposure to antibiotics and individualize treatment in hospitalized old patients with pneumonia: a randomised study. BMC geriatrics. 2022;22(1):965. Search in Google Scholar

24 DAUBIN C., VALETTE X., THIOLLIERE F., MIRA J. P., HAZERA P., ANNANE D., et al. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study. Intensive care medicine. 2018;44(4):428–437. Search in Google Scholar

25 SAVVATEEVA E. N., RUBINA A. Y., GRYADUNOV D. A. Biomarkers of Community-Acquired Pneumonia: A Key to Disease Diagnosis and Management. BioMed research international. 2019;1701276. Search in Google Scholar

26 KAMAT I. S., RAMACHANDRAN V., ESWARAN H., GUFFEY D., MUSHER D. M. Procalcitonin to Distinguish Viral from Bacterial Pneumonia: A Systematic Review and Meta-analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020;70(3):538–542. Search in Google Scholar

27 LIU D., SU L. X., GUAN W., XIAO K., XIE L. X. Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis. Respirology (Carlton, Vic.). 2016;21(2):280-288. Search in Google Scholar

28 SCHUETZ P., WIRZ Y., SAGER R., CHRIST-CRAIN M., STOLZ D., TAMM M. et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10(10):CD007498. Search in Google Scholar

29 AABENHUS R., JENSEN J.U., JORGENSEN K.J., HROBJARTSSON A., BJERRUM L. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev. 2014;(11):CD010130. Search in Google Scholar

30 SCHUETZ P., BEISHUIZEN A., BROYLES M., FERRER R., GAVAZZI G., GLUCK E., et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clinical Chemistry and Laboratory Medicine (CCLM). 2019;57(9):1308-1318. Search in Google Scholar

31 SCHUETZ P., BALK R., BRIEL M., KUTZ A., CHRIST-CRAIN M., STOLZ D., et al. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med. 2015;53(4):583-592. Search in Google Scholar

32 WESTWOOD M., RAMAEKERS B., WHITING P., TOMINI F., JOORE M., ARMSTRONG N., et al. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(96):v-236. Search in Google Scholar